Skip to main content
Ray Page, DO, Oncology, Weatherford, TX

Ray Page DO PhD


Past President, The Center for Cancer and Blood Disorders

Join to view full profile
  • 920 Santa Fe DrWeatherford, TX 76086

  • Phone+1 817-759-7000

  • Fax+1 817-759-7027

Dr. Page is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Ray Page, DO, is an oncology specialist based in Weatherford, TX. He completed his fellowship in Hematology and Medical Oncology at the University of Texas Health Science Center at Houston/M D Anderson Cancer Center. He holds a PhD in Biology (Pharmacology) from the University of North Texas and additional degrees in Physiology, Chemistry, and Biology. Dr. Page has held multiple roles, including President and Physician at The Center for Cancer and Blood Disorders, Clinical Assistant Professor at the University of Texas Southwestern Medical School, and Associate Director of Cancer Developmental Therapeutics at the Institute of Cancer Research. He is experienced in conditions such as amyloidosis and hematologic oncology and has been involved in numerous clinical trials, including those on therapies for small cell lung cancer and chronic lymphocytic leukemia.

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1994 - 1997
  • Osteopathic Medical Center of Texas
    Osteopathic Medical Center of TexasResidency, Internal Medicine, 1991 - 1994
  • University of North Texas
    University of North TexasPhD, Biology (Pharmacology), 1986 - 1991
  • Texas College of Osteopathic Medicine
    Texas College of Osteopathic MedicineClass of 1991
  • Baylor College of Dentistry
    Baylor College of DentistryMS, Physiology, 1984 - 1986

Certifications & Licensure

  • TX State Medical License
    TX State License 1992 - 2027
  • Oncology
    AOA Board of Internal Medicine Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2013-2015
  • Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2011-2014
  • Distinguished Alumnus Grand Prairie High School, 2010

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Breast Cancer International Research Group. Adjuvant trastuzumab in HER2-positive breast cancer.  
    Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M, Pinter T, Valero V, Liu MC, Sauter G, von Minckwitz G, Visco F..., N Engl J Med, 10/1/2011
  • A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell...  
    Blumenschein GR Jr, Kabbinavar F, Menon H, Mok TS, Stephenson J, Beck JT, Lakshmaiah K, Reckamp K, Hei YJ, Kracht K, Sun YN, Sikorski R, Schwartzberg L; Motesanib NSCL..., Ann Oncol, 9/1/2011
  • Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial.  
    Coiffier B, Osmanov EA, Hong X, et. al, Lancet Oncol, 8/1/2011

Books/Book Chapters

Abstracts/Posters

  • Medicare 2005 Demonstration Project: Patient reporting of nausea symptoms and its impact on improving quality of patient care.
    Mueller, B. and Page, R.D., ASCO Proceedings, 1/1/2007
  • Pilot study to determine the effects of dronabinol on hot flash relief in breast cancer patients.
    Schrock, N., Weikel, J., Holland, L., Hiatt, M., Friess, G., and Page, R.D., Journal of the American Osteopathic Association, 1/1/2004
  • Pilot study to determine the effects of dronabinol on hot flash relief in breast cancer patients.
    Schrock, N., Weikel, J., Holland, L., Hiatt, M., Friess, G., and Page, R.D., ASCO Proceedings, 1/1/2004

Lectures

  • "Experience with Via OncologyTreatment Pathways in Community Practice" 
    Fox-Chase Cancer Center, Philadelphia, PA - 12/1/2011
  • "Prostate Cancer Update" 
    Fort Worth, Tx - 11/1/2011
  • "Cancer Prevention and Early Detection" 
    Fort Worth, Tx - 11/1/2011

Other

  • New Guidelines for the Screening of Cervical Cancer. 
    McClennen, R., Wiggins, J., Page, R.D., Texas D.O.
    10/1/2003
  • Medical Oncology Fellows Home Page (Worl Wide Web/Internet) 
    Page, R.D.
    http://mda.uth.tmc.edu
    1/1/1996
  • Hyperthyroidism: Physical Examination findings. (Audio Visual Presentation) 
    Page, R.D., TCOM LC Files
    1/1/1993

Press Mentions

  • Is Cancer Care Affected by New Autism Indication for Leucovorin Amid Ongoing Shortage?
    Is Cancer Care Affected by New Autism Indication for Leucovorin Amid Ongoing Shortage?February 25th, 2026
  • Cancer Drugs’ Sexual Toxicity Spurs “Call to Action” For Oncologists
    Cancer Drugs’ Sexual Toxicity Spurs “Call to Action” For OncologistsApril 15th, 2025
  • In Growth Spurt Since Joining OneOncology, the Center for Cancer and Blood Disorders in Fort Worth Adds 3 Practices and 14 Physicians
    In Growth Spurt Since Joining OneOncology, the Center for Cancer and Blood Disorders in Fort Worth Adds 3 Practices and 14 PhysiciansJuly 12th, 2021

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: